663932-01-2 Usage
Explanation
This is the full chemical name of the compound, which describes its structure and components.
Explanation
The compound has potential pharmaceutical applications due to its structure and the presence of various functional groups that may contribute to its biological activity.
Explanation
The compound is derived from 1-Isoquinolinecarboxylic acid by attaching a methyl ester group, which can influence its properties and potential applications.
Explanation
1-Isoquinolinecarboxylic acid is a building block for many pharmaceutical drugs, making this derivative a potentially valuable compound for drug development.
Explanation
The presence of these functional groups in the compound's structure can enhance its potential as a drug candidate and contribute to its biological activity.
Explanation
The compound's structure suggests that it may have activity as an enzyme inhibitor or receptor antagonist, which are common mechanisms of action for many drugs.
Explanation
Further research is needed to explore the compound's biological activity and potential therapeutic uses, in order to fully understand its pharmaceutical potential.
Pharmaceutical applications
Potential
Derivative
Methyl ester of 1-Isoquinolinecarboxylic acid
Building block
Pharmaceutical drugs
Functional groups
Phenylsulfonyl, hydroxyl, tetrahydro ring
Possible activity
Enzyme inhibitor or receptor antagonist
Research
Biological activity and therapeutic uses
Check Digit Verification of cas no
The CAS Registry Mumber 663932-01-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,6,3,9,3 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 663932-01:
(8*6)+(7*6)+(6*3)+(5*9)+(4*3)+(3*2)+(2*0)+(1*1)=172
172 % 10 = 2
So 663932-01-2 is a valid CAS Registry Number.
663932-01-2Relevant academic research and scientific papers
Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors
Ma, Dawei,Wu, Wengen,Yang, Guoxin,Li, Jingya,Li, Jia,Ye, Qizhuang
, p. 47 - 50 (2007/10/03)
The synthesis and MMP inhibitory activity of a series of tetrahydroisoquinoline based sulfonamide hydroxamates are described. In nine MMPs tested, most of the compounds display potent inhibition activity except for MMP-7. Some subtle isozyme selectivity is observed by varying the substituents at the 6- and 7-positions and aromatic ring of arylsulfonyl groups.
